Paladin Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.52K Hold
13
﹤0.01% 217
2026
Q1
$6.39K Hold
13
﹤0.01% 216
2025
Q4
$7.53K Hold
13
0.01% 212
2025
Q3
$6.3K Hold
13
﹤0.01% 211
2025
Q2
$5.27K Hold
13
﹤0.01% 212
2025
Q1
$6.47K Hold
13
0.01% 209
2024
Q4
$6.76K Hold
13
0.01% 212
2024
Q3
$8.04K Hold
13
0.01% 207
2024
Q2
$7.04K Hold
13
0.01% 199
2024
Q1
$7.51K Hold
13
0.01% 200
2023
Q4
$6.9K Sell
13
-7
-35% -$3.39K 0.01% 203
2023
Q3
$10.1K Hold
20
0.01% 211
2023
Q2
$10.4K Hold
20
0.01% 215
2023
Q1
$11.5K Buy
+20
New +$11.3K 0.01% 211
2022
Q2
Sell
-24
Closed -$13.2K 492
2022
Q1
$14K Buy
+24
New +$13.8K 0.01% 220

Other funds holding TMO

Paladin Advisory Group's TMO Position: Q2 2026 in Review

Paladin Advisory Group held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 13 shares worth $6.52K. The position accounts for ﹤0.01% of the portfolio, ranked #217.

Paladin Advisory Group first reported a position in TMO in Q1 2022 and has held it in 15 quarters since. The position peaked at $14K in Q1 2022. 1,129 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Paladin Advisory Group held 13 shares of Thermo Fisher Scientific worth $6.52K as of Q2 2026.
  • Paladin Advisory Group left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Paladin Advisory Group's portfolio in Q2 2026, its #217 holding.
  • Paladin Advisory Group first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 15 quarters since.
  • Paladin Advisory Group's Thermo Fisher Scientific position peaked at $14K in Q1 2022.
  • 1,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Paladin Advisory Group's 13F filing for Q2 2026, filed 28 Jul 2026.